ESC 22: Hot Line & Late-breaking Science Video Collection

Published: 24 August 2022

  • Views:

    Views Icon 3163
  • Likes:

    Heart Icon 7

Overview

What's hot at European Society of Cardiology (ESC) Congress 22?

Stay tuned and browse our curated coverage of the latest data in cardiology. 

  • For a concise line up of the most awaited trials join Prof Nicolas Van Mieghem and Dr Joost Daemen and their regular View From the Thoraxcenter series. 
  • For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall talks with principal investigators in her Late-Breaker Discussion Series
  • Short, accessible Expert Interviews conducted with select faculty focusing on data, patient care and the future of their field. 
  • To mark the release of the new ESC Guidelines on Cardio-Oncology, we will feature a 10-minute summary and of t a 10-minute live audience Q&A.
  • We asked some of the most prominent researchers today about their pathways in the Behind the Heart series.

Watch our Radcliffe Premiere TV and be transported to Barcelona. 

More from this programme

Part 1

View From the Thoraxcenter: Review Series

In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022. Which trials should we look out for?

Part 2

Late-breaker Discussion Series With Dr Harriette Van Spall

The Late-breaker discussion series will spotlight some of the most awaited hot line trials from this year's ESC. Stay tuned.

Part 3

ESC Guidelines on Cardio-Oncology: Summary & Question Time

In the first part of the programme chairs of the new ESC Guidelines on Cardio-Oncology, Dr Alexander Lyon and Dr Teresa López-Fernández summarised the key take-home messages.In the second part they answered questions coming from the audience with the moderation of Dr Arjun Ghosh.

Part 4

Hot Line & Late-breaking Interviews

In this series, we will interview the presenters of 20 hot line and late-breaking trials to give you a quick updated on the hottest data in cardiology.

Faculty Biographies

Faiez Zannad

Faiez Zannad

Professor of Therapeutics and Cardiology, Head of CIC

Dr Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).

Dr Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension. 

Dr Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.

View full profile